| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Jul 2024 | 3 Jul 2024 |
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2024 inter alia to consider and approve Increase in Authorized Capital of company and to considered and approve the proposal of issue of equity shares on preferential basic. The Board Meeting to be held on 09/07/2024 has been revised to 12/07/2024 The Board Meeting to be held on 09/07/2024 has been revised to 12/07/2024 (As per BSE Announcement Dated on 08/07/2024) 1. Approved the proposal of issue of equity shares on preferential basic and authorize Mr. Suraj Zanwar to record the names of proposed allottees and to complete all procedural formalities required for preferential issue. 2. Approved the proposal of increase in authorized capital and authorize Mr. Suraj Zanwar- Managing Director to submit details of how much capita needs to be increase before the next board meeting (As per BSE Announcement Dated on 13/07/2024) | ||
| Board Meeting | 14 Jun 2024 | 9 Jun 2024 |
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2024 inter alia to consider and approve To Discuss and reconsider the Investment Planning and Fund-raising Proposal etc. | ||
| Board Meeting | 5 Jun 2024 | 1 Jun 2024 |
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2024 inter alia to consider and approve To Discuss and Consider the Investment Planning and Fund-raising Proposal mode of funding To authorized Mr. Suraj Zanwar- Managing Director of company to prepare details plan of Investment proposal and working capital requirement of the company (As Per BSE Announcement Dated on 09.06.2024) | ||
| Board Meeting | 30 May 2024 | 20 May 2024 |
| Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve To consider and approve Audited financial results for Year ended on 31st march 2024 Revised financials for financial year ending on 31st march 2024 due to mission of attachment consolidated results (As Per BSE Announcement Dated on 31.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
